Phenotype Guided Vasoactive Medication During Kidney Transplantation (NCT07633600)
Intraoperative Circulation Phenotyping to Guide Vasoactive Medication in Kidney Transplant Recipients
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to learn if vasopressin improves the body's response to intravenous fluids during kidney transplantation in patients who have relaxed blood vessels. Researchers will compare the results of vasopressin to those who received calcium chloride.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (3 items) and avoid the listed exclusions (4 items).
Location: Cedars Sinai Medical Center — Los Angeles, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Patients unable to provide informed consent
- Patients with contraindications to protocol vasoactive medications, as determined by the treating anesthesiologist
- Patients in whom required intraoperative monitoring cannot be performed
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (1 Sites)
- Cedars Sinai Medical Center — Los Angeles, California
📞 Contact the Study Coordinator
Phone: (310) 497-4541
Email: jennifer.cutler@cshs.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Kidney Transplant
- Allogeneic Regulatory Dendritic Cell (DCreg) Renal Study — Pittsburgh, Pennsylvania
- CAR-T Cell Therapy for Desensitization in Kidney Transplantation — Boston, Massachusetts
- Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation — Birmingham, Alabama
- Social Support Counseling Intervention for Kidney Transplant Candidates — Minneapolis, Minnesota
- Empagliflozin Treatment in Kidney Transplant Recipients — Hines, Illinois
Explore by condition: All Kidney Transplant clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.